At a glance
ClinicalIndex Comparison RecordN/ACompleted· 558 enrolled
Drug / intervention
kidney transplantationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The EUropean TRAnsplantation and INnovation Consortium for Risk Stratification in Kidney Transplant Patients
In Brief
An observational study evaluating kidney transplantation for Kidney Transplant Rejection and 3 related conditions. Completed, enrolled 558 participants across 9 sites in 4 countries.
Detailed Summary
Main objective: To design a precision risk stratification system that predicts individual risk of rejection
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesFrance, Germany, Spain, Switzerland
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 2018
Enrollment StartNov 2018
Primary CompletionOct 2021
TodayJul 2026
First PostedAug 29, 2018
Enrollment StartNov 27, 2018
Primary CompletionOct 28, 2021
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 7.8 years ago
Interventions
kidney transplantationprocedure
samples additional to the standard of care' (SOC)will be taken at each visit (Day 0, Month 3, Month12, clinical indication)